← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-4 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
ADCBiologicstaleCorbus Pharmaceuticals Inc.Phase 2

CRB-701 (CRB-701)

Solid Tumor, Adult · Solid Tumor, Adult

#SolidTumorAdult#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleCancer Institute and Hospital, …Phase 2

CREPT-618 (CREPT-618)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
CGTBiologicstaleMark Walters, MDPhase 2

CRISPR_SCD001 (CRISPR_SCD001)

Sickle Cell Disease · Sickle Cell Disease

#SickleCellDisease#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleCorregene Biotechnology Co., LtdPhase 1

CRTE7A2-01 TCR-T cell therapy (CRTE7A2-01 TCR-T cell therapy)

Cervical Cancer; Anal Cancer · Cervical Cancer

#CervicalCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
ADCBiologicstaleCStone PharmaceuticalsPhase 1

CS5001 (CS5001)

Advanced Solid Tumor; Advanced Lymphoma · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
CGTAAVBiologicstaleCSL BehringPhase 3

AAV5-hFIXco-Padua (CSL222, CSL222 (AAV5-hFIXco-Padua))

Hemophilia B · Hemophilia B

#HemophiliaB#CGT#Phase3#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 3

Daratumumab (CT-P44, CT-P44(Daratumumab))

Refractory or Relapsed Multiple Myeloma · FRα

#FR#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
CGTBiologicstaleCARsgen Therapeutics Co., Ltd.Preclinical

CT0590 CAR T Cells (CT0590 CAR T Cells)

Relapsed and/or Refractory Multiple Myeloma · FRα

#FR#CGT#Preclinical#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleMEI HENGPhase 1

CT0991 CAR-T cells infusicn (CT0991 CAR-T cells infusicn)

Relapsed/Refractory Acute Myeloid Leukemia(AML) · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleChi Kong LiPhase 2

CUCART19 (CUCART19)

Lymphoma, Nonhodgkin; Leukemia, Lymphocytic · Lymphoma, Nonhodgkin

#LymphomaNonhodgkin#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 1상태 RECRUITING
ADCBiologicstaleOnCusp Therapeutics, Inc.Phase 1

CUSP06 (CUSP06)

Ovarian Cancer; Solid Tumor · Ovarian Cancer

#OvarianCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleConvalife (Shanghai) Co., Ltd.Phase 2

CVL006 combined with pemetrexed and carboplatin (CVL006 combined with pemetrexed and carboplatin)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleCytomX TherapeuticsPhase 2

CX-2009 (CX-2009)

Solid Tumor, Adult; Breast Cancer · Solid Tumor, Adult

#SolidTumorAdult#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 0%임상시험 1상태 DISCONTINUED
ADCBiologicstaleCytomX TherapeuticsPhase 2

CX-2029 (CX-2029)

Solid Tumor, Adult; Head and Neck Cancer · Solid Tumor, Adult

#SolidTumorAdult#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 1상태 ACTIVE
CGTBiologicstaleSichuan UniversityPhase 1

CXCR4 modified anti-BCMA CAR T cells (CXCR4 modified anti-BCMA CAR T cells)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

CYCLOSPORINE VS INFLIXIMAB (CYCLOSPORINE VS INFLIXIMAB)

Ulcerative Colitis; Steroid Refractory · FRα

#FR#Antibody#Approved#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleBristol-Myers SquibbPhase 2

Cabiralizumab (Cabiralizumab)

Advanced Pancreatic Cancer · Triple Negative Breast Cancer

#TripleNegativeBreastCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 20%임상시험 1상태 ACTIVE
AntibodystaleUniversity of ArizonaPhase 2

atezolizumab (Tecentriq, Cabozantinib + Atezolizumab)

Pancreatic Cancer; Metastatic Pancreatic Cancer · Pancreatic Cancer

#PancreaticCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleCaigang LiuPhase 3

Cadonilimab (AK104, Cadonilimab, Cadonilimab (AK104) combined with chemotherapy and bevacizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleShen FengPhase 2

Cadonilimab+Gem/Cis (Cadonilimab+Gem/Cis)

Intrahepatic Cholangiocarcinoma · Intrahepatic Cholangiocarcinoma

#IntrahepaticCholangiocarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE

100 / 177 페이지

← 이전다음 →